
ALLO Market Cap & Key Metrics
Allogene Therapeutics, Inc.
$0.67
-$0.03(-4.17%)
33
Overall
60
Value
18
Tech
21
Quality
Market Cap
$231.06M
Volume
7.23M
52W Range
$0.82 - $4.46
Target Price
$8.30
ALLO market cap is $231.06M. This page lists Allogene Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
ALLO Key Metrics
- Market cap
- $231.06M
- EPS estimate, current year
- $-0.58
- EPS growth, 3-year
- +0.00%
- Value score
- 60
- Quality score
- 21
- Technical score
- 18
| Fiscal year | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | $156.0K | $38.49M | - | - | - |
| EBITDA | -$321.24M | -$169.74M | -$250.66M | -$179.90M | -$203.41M |
| EPS | $-2.32 | $-1.89 | $-2.08 | $-1.83 | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALLO | $0.67 | -4.2% | 7.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Allogene Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW